Together with the finding that LGR6 is hypermethylated in up to 50% of colon cancer samples and an LGR6 truncation mutant has been identified in ovarian cancer, these data imply that LGR6 functions as tumor suppressor for colon and ovarian cancer. This evidence concerns the gene LGR6 and ovarian cancer.